JENNIFER ROY: Open Payments
NPI 1265290100 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 26 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $417 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $164 |
| Geron Corporation | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Genentech USA, Inc. | 2 | $44 |
| Celgene Corporation | 2 | $39 |
| TerSera Therapeutics LLC | 1 | $36 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| JAZZ PHARMACEUTICALS INC. | 1 | $24 |
Products named: OPDIVO, RYTELO, KISQALI, REBLOZYL, Xermelo, INJECTAFER, Phesgo, Nubeqa.
Industry payments across SC — which companies pay providers there.
